Heart ultrasound and biomechanical evaluation of radiation-induced heart toxicity using transthoracic echocardiogram(TTE) and dynamicmechanical analysis (DMA)

Abstract

Radiation-induced heart disease (RIHD) is a serious complication but difficult to assess in patients undergoing thoracic radiotherapy (RT). We aim to analyze RIHD using heart ultrasound and elastic modulus, exploring relationships between functional, anatomical or biomechanical changes of the heart and radiation dose.

Twenty BALB/c mice were divided into four groups (control, 10 Gy, 20 Gy and 25 Gy) with a single fraction of image-guided volumetric modulated arc radiotherapy (VMAT) to murine heart on a linear accelerator. Transthoracic echocardiography (TTE) was performed on a small-animal ultrasound imaging system with a handheld microscan transducer. E-wave/A-wave ratio (E/A) and myocardial performance index (MPI) for diastolic performancewere noninvasively evaluatedweekly, aswell as ejection fraction (EF%), fractional shortening (FS%), left ventricle (LV) mass and heart wall thickening for systolic performance. At the end of the fifth week, all mice were sacrificed for elastic modulus measurement on a dynamic mechanical analyzer (DMA) and for histopathological staining. All experiments were conducted in accordance with the local institution’s animal research committee guideline.

Significant difference was observed in E/A ratio between the control and 25 Gy irradiated groups (1.8±0.5 and 0.7±0.9, respectively; p<0.05), indicating reduced diastolic performance and increased stiffness in left ventricle after high-dose heart radiation. Diastolic dysfunction in irradiated groups was also observed with significantly increased MPI. In contrast, posterior wall thickness, aortic peak velocity, heart rate, EF and FS were not significantly different after RT. Heart elasticity was reduced substantially with the increased radiation dose. HE and Masson Trichrome staining confirmed more fibrosis deposition in irradiated hearts.

RIHD evaluation with ultrasound imaging noninvasively and biomechanical modulus measurement invasively in the image guided, precision dose-escalated murine heart irradiation is feasible. Increased myocardial stiffness, abnormal diastolic relaxation, more collagen deposition, and reduced tissue elasticity are observed in irradiated heart tissue. This study may facilitate our understanding of RIHD and facilitate improving patients’ quality of life in the future.

Keywords

echocardiogram / elastic modulus / radiation-induced heart disease

References

[1] DarbySC, EwertzM, McGaleP, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998.

[2] Van Den BogaardVAB, Ta BDP, Van Der SchaafA, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treatedwith radiotherapy based on threedimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35:1171–1178.

[3] StamB, PeulenH, GuckenbergerM, et al. Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. Radiother Oncol. 2017;123:370–375.

[4] VivekanandanS, LandauDB, CounsellN, et al. The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99:51–60.

[5] AtkinsKM, Chaunzwa TL, LambaN, et al. Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 2021;7:206e219.

[6] HerrmannJ. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020;17(8):474-502.

[7] ChowEJ, ChenY, HudsonMM, et al. Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. J Clin Oncol. 2018;36(1):44-52.

[8] LeerinkJM, de Baat EC, FeijenEAM, et al. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review. JACC CardioOncol. 2020;2(3):363-378.

[9] ChokseyA, TimmKN. Cancer Therapy-Induced Cardiotoxicity-A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy. Int J Mol Sci. 2021;23(1):441.

[10] AtunR, Jaffray DA, BartonMB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015;16(10):1153-1186.

[11] CuculichPS, SchillMR, KashaniR, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377;2325–2336.

[12] BlanckO, BodeF, GebhardM, et al. Dose-escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys. 2014;89(3):590-598.

[13] KovacsB, Mayinger M, SchindlerM, SteffelJ, Andratschke N, SagunerAM. Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease - A systematic review. Radiother Oncol. 2021;162:132-139.

[14] WangH, WeiJ, ZhengQ, et al. Radiation-induced heart disease: a review of classification, mechanism and prevention. Int J Biol Sci. 2019;15(10):2128-2138.

[15] SridharanV, Aykin-Burns N, TripathiP, et al. Radiation-induced alterations in mitochondria of the rat heart. Radiat Res. 2014;181(3):324-334.

[16] SuchorskaWM. Radiobiological models in prediction of radiation cardiotoxicity. Rep Pract Oncol Radiother. 2020;25(1):46-49.

[17] YangR, TanC, NajafiM. Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents. Inflammopharmacology. 2022;30(1):73-89.

[18] LoapP, KirovK, KirovaY. Cardiotoxicity in breast cancer patients treated with radiation therapy: From evidences to controversies. Crit Rev Oncol Hematol. 2020;156:103121.

[19] ZhangDM, NavaraR, YinT, et al. Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis. Nat Commun. 2021;12(1):5558.

[20] GhitaM, GillEK, WallsGM, et al. Cardiac sub-volume targeting demonstrates regional radiosensitivity in the mouse heart. Radiother Oncol. 2020;152:216-221.

[21] SchnelleM, Catibog N, ZhangM, et al. Echocardiographic evaluation of diastolic function in mouse models of heart disease. J Mol Cell Cardiol. 2018;114:20-28.

[22] GaoS, HoD, VatnerDE, Vatner SF. Echocardiography in Mice Echocardiography in Mice. Curr Protoc Mouse Biol. 2011;1:71-83.

[23] LindseyML, Kassiri Z, ViragJAI, de Castro BrásLE, Scherrer-CrosbieM. Guidelines for measuring cardiac physiology in mice. Am J Physiol Heart Circ Physiol. 2018;314(4):H733-H752.

[24] ThavendiranathanP, Grant AD, NegishiT, PlanaJC, Popovic ZB, MarwickTH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:77–84.

[25] ArmstrongGT, PlanaJC, ZhangN, et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol. 2012;30:2876–2884.

[26] SchöllnbergerH, Eidemüller M, CullingsHM, SimonettoC, NeffF, KaiserJC. Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors:1950–2003. Radiat Environ Biophys. 2018;57(1):17-29.

[27] HatchM, CardisE. Somatic health effects of Chernobyl:30 years on. Eur J Epidemiol. 2017;32(12):1047-1054.

[28] daSilvaRMFL. Effects of Radiotherapy in Coronary Artery Disease. Curr Atheroscler Rep. 2019;21(12):50.

[29] PirothMD, Baumann R, BudachW, et al. Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention. Strahlenther Onkol. 2019;195(1):1-12.

[30] DesaiMY, Windecker S, LancellottiP, et al. Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74(7):905-927.

[31] LancellottiP, NkomoVT, BadanoLP, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14:721–740.

[32] JerajR, CaoY, TenHakenRK, Hahn C, MarksL. Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S140-S144.

[33] RodemannHP, BlaeseMA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol. 2007;17(2):81-88.

[34] WangK, Pearlstein KA, PatchettND, et al. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on doseescalation trials for Stage III non-small-cell lung cancer. Radiother Oncol. 2017;125(2):293-300.

RIGHTS & PERMISSIONS

2024 The Author(s). Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.